The effect of adrenergic blockade on the insulin release after intraduodenal glucose in man.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D004386:Duodenum; D005749:Gastric Inhibitory Polypeptide / Q000378:metabolism; D005950:Glucose Solution, Hypertonic / Q000494:pharmacology; D006801:Humans; D007267:Injections; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012965:Sodium Chloride / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D005950:Glucose Solution, Hypertonic; D007328:Insulin; D012965:Sodium Chloride; D005749:Gastric Inhibitory Polypeptide; D011433:Propranolol; D010646:Phentolamine